This study explores the regulatory genome of Parkinson’s disease using bioinformatics tools to identify key genes, variants, and pathways. Analysis of GEO datasets revealed targets linked to neuroinflammation, mitochondrial function, and synaptic signaling, offering insight into potential therapeutic avenues for the disease.